Iron (ferric carboxymaltose class)

Pregnancy & gynaecology-specific. Every dose row is source-referenced; verify against institutional protocols.

Iron (ferric carboxymaltose class)IV iron complex

Regimens checked: 2026-10-17. Each indication has its own preparation, limits and safety checks.

Iron (ferric carboxymaltose class): indication-specific regimens
Indication	Dose	Route	Frequency	Duration / preparation	Maximum	Monitoring / cautions
Laboratory-confirmed iron deficiency when oral iron is ineffective/intolerable or faster replacement is indicated; assess trimester and infection CSL Vifor / emcchecked	Determine TOTAL need from Hb and weight, then give up to 20 mg/kg per infusion, not exceeding 1000 mg	IV infusion only	Repeat only if calculated deficit remains; additional dose at least 7 days later	Finite replacement course, not automatic weekly indefinite treatment · 50 mg iron/mL: 1000 mg =20 mL. For >500–1000 mg dilute only in up to 250 mL sodium chloride 0.9% and infuse over at least 15 min. Do not dilute below 2 mg/mL Label total-need table: Hb <10 g/dL: 35–<70 kg 1500 mg, ≥70 kg 2000 mg. Hb 10–<14: 1000 mg and 1500 mg respectively. Hb ≥14: 500 mg. Below 35 kg: use the label weight-based calculation. A 60 kg patient with Hb 8 g/dL therefore needs 1500 mg TOTAL, split 1000 mg then 500 mg ≥7 days later; 1000 mg is not automatically the full deficit.	Lesser of 20 mg/kg or 1000 mg per infusion; maximum 1000 mg/week for adults in this Ferinject label	Monitor Observe during and at least 30 min after infusion with anaphylaxis treatment available; monitor extravasation Hb reassessment no earlier than 4 weeks after final dose; phosphate for repeated/high-dose courses or symptoms Contraindications / cautions Non-iron-deficiency anaemia, iron overload or serious parenteral-iron hypersensitivity Restrict pregnancy treatment to clear indications in the second/third trimester; avoid during ongoing bacteraemia

Pregnancy safety

Use only for a clear indication; the cited product restricts pregnancy use to the second/third trimester after benefit-risk assessment.

Lactation

Compatible

CSL Vifor / emccheckedIN REVIEW